Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS).

Diabetes - GeneralType 2 DiabetesGlycemic Control
Do you want to read an article? Please log in or register.